Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset

Synapse
G M MackenzieC D Marsden

Abstract

Nitric oxide, produced following activation of N-methyl-D-aspartate (NMDA) receptors, may be involved in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity since NMDA receptor antagonists have been shown to prevent MPTP induced nigral cell loss in primates. Common marmosets were treated with either saline or MPTP or L-NGnitro arginine methyl ester (L-NAME) or MPTP and L-NAME. MPTP-treated common marmosets showed motor deficits including bradykinesia, rigidity, and tremor accompanied by a marked loss of tyrosine hydroxylase-immunoreactive neurones in the substantia nigra pars compacta and of [3H]-mazindol binding in the caudate-putamen. MPTP treatment also caused an increase in glial fibrillary acidic protein (GFAP) staining in the substantia nigra compared to controls. However, MPTP treatment did not alter the number of constitutive nitric oxide synthase-immunoreactive neurones in the caudate-putamen. Furthermore, neurones or glial cells immunoreactive for inducible nitric oxide synthase were not observed in the substantia nigra pars compacta following MPTP treatment. L-NAME treatment alone did not produce any behavioural changes in marmosets and did not alter the number of tyrosine hydroxylase-immunoreactive cells in...Continue Reading

References

Jan 1, 1992·Neuroscience·S R Vincent, H Kimura
Sep 1, 1992·Annals of Neurology·T M DawsonS H Snyder
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D S Bredt, S H Snyder
Mar 30, 1987·Biochemical and Biophysical Research Communications·Y MizunoN Sone
Mar 1, 1994·The Biochemical Journal·R G Knowles, S Moncada
Sep 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P A KellyG W Arbuthnott
Aug 1, 1993·European Journal of Biochemistry·V Riveros-MorenoS Moncada
Jan 16, 1995·European Journal of Pharmacology·M S Starr, B S Starr
Jul 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·I Prohovnik
Mar 1, 1994·Neurobiology of Aging·G D ZeevalkP K Sonsalla
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·S PrzedborskiT M Dawson
Nov 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·R K PearceC D Marsden

❮ Previous
Next ❯

Citations

Apr 1, 2003·Annals of Neurology·Peter Jenner
Feb 1, 2002·European Journal of Pharmacology·Mohamed A Elwan, Norio Sakuragawa
Nov 14, 2002·Neurotoxicology·Donato A Di MonteAmy B Manning-Bog
Aug 15, 1998·Journal of Chemical Neuroanatomy·K P Mohanakumar, H W Steinbusch
Oct 3, 2002·Journal of Neurochemistry·Allen S MandirTed M Dawson
Aug 31, 2006·Behavioural Pharmacology·Sanneke A M van VlietIngrid H C H M Philippens
May 20, 1999·Annual Review of Pharmacology and Toxicology·A J HobbsS Moncada
Aug 26, 1998·Reviews in the Neurosciences·E BezardC E Gross
Sep 29, 2007·Neurochemistry International·Trine R LarsenJan Bert Gramsbergen
Oct 16, 2010·Journal of Pharmacological Sciences·Mohammed Emamussalehin ChoudhuryMasahiro Nomoto
Feb 24, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P RauhalaC C Chiueh
Jun 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M H TranT Nabeshima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.